AGNUCASTON Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

agnucaston

bionorica se - germania - plante - compr. film. - alte medicamente ginecologice alte medicamente ginecologice

CYCLODYNON Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cyclodynon

bionorica se - germania - plante (extract din fruct de scai de tufa mare) - compr. film. - alte medicamente ginecologice alte medicamente ginecologice

Sitagliptin SUN Unión Europea - rumano - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Sitagliptin Accord Unión Europea - rumano - EMA (European Medicines Agency)

sitagliptin accord

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Memantine LEK Unión Europea - rumano - EMA (European Medicines Agency)

memantine lek

pharmathen s.a. - memantină clorhidrat - boala alzheimer - psychoanaleptics, , alte medicamente pentru tratamentul demenței - tratamentul pacienților cu boală alzheimer moderată până la severă.

Onglyza Unión Europea - rumano - EMA (European Medicines Agency)

onglyza

astrazeneca ab - saxagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

FEMIBEN Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

femiben

schaper&brÜmmer gmbh & co. kg - germania - plante (vitex agnus cast) - caps. - alte medicamente ginecologice alte medicamente ginecologice

FEMIBEN Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

femiben

schaper&brÜmmer gmbh & co. kg - germania - plante (vitex agnus cast) - caps. - alte medicamente ginecologice alte medicamente ginecologice

FEMIPLANTE Rumanía - rumano - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

femiplante

schaper&brÜmmer gmbh & co. kg - germania - plante (vitex agnus cast) - caps. - alte medicamente ginecologice alte medicamente ginecologice

Teriparatide Sun Unión Europea - rumano - EMA (European Medicines Agency)

teriparatide sun

sun pharmaceutical industries europe b.v. - teriparatidul - osteoporosis; osteoporosis, postmenopausal - homeostazia de calciu - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.